Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status.

L SchubertA M Mbekwe-YepnangJ WassermannY Braik-DjellasL JaffrelotF PaniG DeniziautC Lussey-LepoutreN ChereauL LeenhardtM- O BernierCamille Buffet

Published in: Journal of endocrinological investigation (2024)

Predicting the occurrence of RAIR-disease in DTC patients may allow clinicians to focus on systemic redifferentiating strategies and/or local treatments for metastatic lesions rather than pursuing with ineffective RAI-therapies.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
squamous cell carcinoma
small cell lung cancer
prognostic factors
patient reported outcomes
drug induced